Osteogenics Biomedical Introduces enCore® 50/50 Allograft

140729 osteogenics feature1

LUBBOCK, Texas – Osteogenics Biomedical, a leader in the development of innovative dental bone grafting products, introduces enCore® 50/50 Cortical and Cancellous Allograft to compliment the family of enCore® Allografts.

The 50/50 allograft combines space maintaining cortical bone with porous, faster resorbing cancellous bone in a single bottle.

All lots of enCore® 50/50 Cortical & Cancellous allograft are sourced from a single donor.

In addition to the new 50/50 allograft, Osteogenics offers the popular enCore® 70/30 Combination allograft composed of mineralized cortical bone and osteoinductive demineralized matrix, as well as a 100 percent mineralized cortical allograft.

All of the allografts are available in a variety of volume sizes to treat a wide range of bony defects and are processed by Allotech, an FDA-registered and AATB-accredited tissue bank.

For more information about enCore® Allografts, visit osteogenics.com, or contact a customer service representative at 888.796.1923.

Stay Relevant with Implant Practice US

Join our email list for CE courses and webinars, articles and mores

Read our following terms and conditions before subscribing.

Terms and Conditions checkbox is required.
Something went wrong. Please check your entries and try again.


Implant Practice US is a leading dental journal and publication for dental implantology continuing education, oral implantology case studies, and more. Subscribe to Implant Practice US today!


Earn dental continuing education credits as an Implant Practice US subscriber. Log in for online dental CE credits now!


Copyright © 2021 Orthodontic Practice US - Dental Journal and Online Dental CE | MedMark LLC
15720 North Greenway Hayden Loop, Suite #9 Scottsdale, AZ 85260 | All rights Reserved | Privacy Policy | Terms & Conditions

Scroll to Top